Page 11 - CLT020121

NEWS FEBRUARY 1, 2021 ¦ 11

located. This means there is no one office with a nies face, and we are trial lawyers who are in court
higher concentration of litigators than others. nearly every day, which is a powerful combination
That said, our offices do line up strategically in for our clients.
key regions where there are large concentrations of International Trade Commission (ITC): We’ve
technology and life sciences companies, like Atlanta, been active in the ITC since long before the rush to
Boston, New York, Twin Cities, Southern Califor- appear in its chambers and have the deepest bench
nia, Silicon Valley, and Shenzhen, China. Other and most winning track record in the industry.
offices like D.C., Wilmington, Dallas, Houston, and Over the past 20 years, we have been involved in
Austin are near the busiest patent jurisdictions and more than 135 ITC investigations and have played
venues. Our Munich, Germany, office is important a role in nearly every hot-button ITC issue, from
because the European and German Patent Offices changing the law regarding “downstream products”
and the German Federal Patent Court are located to advancing the standards for when non-practicing
there, so it’s a pivotal base of operations for our Eu- entities can litigate in the ITC to participating in
ropean clients. unprecedented hearings before the full Commission
regarding public interest issues. The ITC is a spe-
In what three areas of litigation do you have the cialized venue with its own rules and procedures,
and we know the process, the judges, and the law
deepest bench?
Technology: There is no firm with a deeper bench better than anyone else.
of technology lawyers than Fish. We have over 100
attorneys with electrical engineering or mechanical As head of the department, what are some of
engineering degrees. We speak our clients’ lan- your goals or priorities? What do you see as hall-
guage. This vast technical knowledge combined marks of your firm’s litigators? What makes you
with our trial prowess is why the largest technol- different?
ogy companies in the world, including Microsoft, Fish handles more patent cases in district court,
Samsung and LG Electronics among many others, at the ITC, and at the Court of Appeals for the Fed-
trust us with their most important global IP litiga- eral Circuit than any other firm. We have also been
tion. Of the so-called Patent Elite companies, which the most active firm at the Patent Trial and Appeal
own the 100 largest portfolios of granted, in-force Board (PTAB) for the past four consecutive years.
U.S. patents, we represent five of the top 10 compa- PTAB trials have become an essential strategic tool
nies (all technology companies) that filed the most to help our clients achieve defensive and offensive
patent litigation over the past 10 years (2009-2019). patent litigation success. We obviously want to
Overall, we represented 59 of the 100 Patent Elite maintain and build on our leadership position in all
companies–more than any other firm–and handled these areas. When you are number one, you want
more patent litigation in U.S. district courts than to stay number one, and that means constantly im-
our competitors by a large margin. proving how we service clients and how we help
Life sciences: We represent branded phar- them meet their business objectives.
maceutical clients, such as Gilead Sciences and We are a firm with a very specific focus and ex-
GlaxoSmithKline, in their highest-stakes, global pertise, and a loyal client base who hire us when
life sciences and Hatch-Waxman litigation. We the stakes are high and they need the most ex-
also have a strong biosimilars litigation practice perienced legal counsel on their side. One of our
that has grown significantly over the past several greatest strengths is handling large-scale, com-
years. Our bench includes more than 115 attorneys petitor-to-competitor patent disputes requiring
and technical specialists holding biology, chemis- extensive global litigation coordination. One prior-
try, or genetic engineering degrees, including over ity is to continue to be the go-to firm for companies
50 with Ph.D.s. We are scientists who understand that need sophisticated counsel to develop and
the unique challenges that life sciences compa-
¦ Continued on PAGE 12

CONNECTICUT
Law Tribune